Home/Genscript Biotech/Dr. Frank Zhang (Zhang Fangliang)
DF

Dr. Frank Zhang (Zhang Fangliang)

Founder, Chairman, CEO

Genscript Biotech

Therapeutic Areas

Genscript Biotech Pipeline

DrugIndicationPhase
Ciltacabtagene autoleucel (Carvykti)Relapsed/Refractory Multiple MyelomaApproved / Phase 3
LB1901Relapsed/Refractory T-cell LymphomaPhase 1
LB2102Extensive-Stage Small Cell Lung CancerPhase 1
LB1911Pancreatic Cancer, Colorectal CancerPreclinical / Phase 1 (planned)